Investigational Site Number: 6160009

Poznan 60-702

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis — Completed
• Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin — Stopped early